B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Nafamostat

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nafamostat, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

camostat
5 shared targets
efegatran
4 shared targets
benzamidine
3 shared targets
leupeptin
4 shared targets
dx
3 shared targets
dabigatran
4 shared targets
Gabexate
4 shared targets · score 50.2
l
2 shared targets
l
2 shared targets
melagatran
3 shared targets
Loading evidence profile...

This evidence profile for Nafamostat is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.